Bosulif is a medication that belongs to a class of drugs known as tyrosine kinase inhibitors. It is commonly prescribed for the treatment of a type of blood cancer called chronic myeloid leukemia (CML) in adults who have not responded well to other treatments or have developed resistance to other medications.

Bosulif works by blocking the action of certain proteins in cancer cells that are responsible for their growth and division. By inhibiting these proteins, Bosulif helps to slow down or stop the growth of cancer cells, ultimately leading to a reduction in the size of the tumor and improvement in symptoms.

It is important to take Bosulif exactly as prescribed by your healthcare provider, as the dosage and frequency of administration will vary depending on your individual condition and response to treatment. It is typically taken orally, with or without food, once daily.

Like all medications, Bosulif may cause side effects in some individuals. Common side effects may include diarrhea, nausea, vomiting, abdominal pain, fatigue, and rash. It is important to report any side effects to your healthcare provider, as they may be able to provide guidance on how to manage or alleviate these symptoms.

Before starting Bosulif, it is important to inform your healthcare provider about any other medications or supplements you are taking, as they may interact with Bosulif and affect its effectiveness or increase the risk of side effects.

Overall, Bosulif is an important treatment option for individuals with CML who have not responded well to other therapies. It is important to work closely with your healthcare provider to monitor your progress and adjust your treatment plan as needed.